The FDA has approved a new four-dose, single-patient-use KwikPen for Zepbound (tirzepatide), giving patients a full month of treatment in one device.
Eli Lilly announced on "Good Morning America" Monday that its GLP-1 weight-loss drug Zepbound will now be available in a new ...
The FDA has approved a label expansion for once-weekly tirzepatide for adults with overweight and obesity, allowing the medication to be used with a pen that is equipped with four doses of the drug, ...
The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular ...
SPONSORED: Not sure which GLP-1 is right for you? A St. Joseph Health nurse practitioner explains the key differences between ...
Eli Lilly said the drug will be available at the same self-pay price in either the multi-dose pen or single-dose vial format, starting at $299 a month for the 2.5-milligram starter dose through ...
GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced employer-sponsored access ...
Phoenix NP, a women-focused telehealth medical practice based in Phoenix, Arizona, has announced the availability of FDA-approved Zepbound (tirzepatide) as part of its medical weight management ...
The Food and Drug Administration’s crackdown on cheaper, independently produced versions of popular weight-loss and diabetes medications stoked anger and pushback from users, sellers and the Alliance ...
The Food and Drug Administration (FDA) on Tuesday sent 30 telehealth companies warning letters about their “illegal” sales of compounded GLP-1s, building off increasing pressure to tamp down on the ...
The Food and Drug Administration (FDA) has approved some medications for weight loss. If a medication is FDA-approved, it means the FDA has determined it’s safe and effective for a certain use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results